New Delhi: Unichem Laboratories on Monday posted 11.14 per cent rise in net profit at Rs 25.76 crore for the first quarter ended June 30.
The company had posted a net profit of Rs 28.99 crore during the same period a year ago.
However, net sales of the firm rose to Rs 334.9 crore as compared to Rs 304.49 crore during the same period of previous fiscal, Unichem Laboratories said in a BSE filing.
Unichem Laboratories manufactures and markets a large basket of pharmaceutical formulations in India and several other markets across the world.
In India, the company is a leader in niche therapy areas of cardiology, neurology, orthopedics and anti-infectives.
Shares of the compay were trading 3.59 per cent down at Rs 292.40 apiece on BSE.
New Delhi: Unichem Laboratories on Monday posted 11.14 per cent rise in net profit at Rs 25.76 crore for the first quarter ended June 30.
The company had posted a net profit of Rs 28.99 crore during the same period a year ago.
However, net sales of the firm rose to Rs 334.9 crore as compared to Rs 304.49 crore during the same period of previous fiscal, Unichem Laboratories said in a BSE filing.
Unichem Laboratories manufactures and markets a large basket of pharmaceutical formulations in India and several other markets across the world.
In India, the company is a leader in niche therapy areas of cardiology, neurology, orthopedics and anti-infectives.
Shares of the compay were trading 3.59 per cent down at Rs 292.40 apiece on BSE.
New Delhi: Unichem Laboratories on Monday posted 11.14 per cent rise in net profit at Rs 25.76 crore for the first quarter ended June 30.
The company had posted a net profit of Rs 28.99 crore during the same period a year ago.
However, net sales of the firm rose to Rs 334.9 crore as compared to Rs 304.49 crore during the same period of previous fiscal, Unichem Laboratories said in a BSE filing.
Unichem Laboratories manufactures and markets a large basket of pharmaceutical formulations in India and several other markets across the world.
In India, the company is a leader in niche therapy areas of cardiology, neurology, orthopedics and anti-infectives.
Shares of the compay were trading 3.59 per cent down at Rs 292.40 apiece on BSE.
Sign Up with Google
RECOMMENDED FOR YOU
POPULAR